The IsoFlux System enables molecular analysis from circulating tumor cells (CTCs) obtained from a routine blood draw. The system enriches CTCs or other rare circulating cells from peripheral blood and prepares them for molecular analysis, including NGS, qPCR, FISH, and immunofluorescence. The resulting samples have the required tumor DNA content and purity to be used with the leading NGS content panels.